baber/WOPTO huggingface dataset:
Patent AU-2002214303-B2 (AU)
Title: Gene encoding acetolactic acid synthase gene
Inventor: TANAKA YOSHIYUKI
IPC: C12N15/60
Filed: 2001-11-16
Granted: 2007-11-01
Abstract: The present invention provides a gene encoding ALS protein which shows extremely high level of resistance to PC herbicides. The gene of the present invention encodes the following protein (a) or (b):  (a) a protein which comprises an amino acid sequence of SEQ ID NO: 1; (b) a protein which comprises an amino acid sequence derived from the amino acid sequence of SEQ ID NO: 1 by substitution, deletion or addition of at least one or more amino acids, has resistance to a pyrimidinyl carboxy herbicide and has acetolactate synthase activity.
Patent AU-2002226451-B2 (AU)
Title: Method and apparatus for forming a projection screen or a projection volume
Inventor: RAKKOLAINEN ISMO
IPC: G03B21/60
Filed: 2002-01-15
Granted: 2006-08-03
Abstract: The invention relates to a method for producing a non-solid projection screen (3), projection volume (8), or the like, the method comprising the steps of supplying and/or forming light scattering/reflecting scattering centres (4) to a substantially laminar transfer flow (2) to be transferred by said transfer flow (2). In accordance with the invention, the scattering centres (4) are supplied and/or formed to the transfer flow (2), to the central/inner parts thereof that remain laminar, away from the direct vicinity of the interfaces between the transfer flow (2) and the area surrounding thereof, in order to keep the projection screen in shape. In accordance with the invention, as the scattering centres (4) can be used light elastically or non-elastically scattering, solid liquid or gaseous substance.
Patent AU-2002335770-B2 (AU)
Title: Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
Inventor: DAVIS HARRY R
IPC: C07D205/08
Filed: 2002-09-19
Granted: 2005-08-18
Abstract: The present invention provides methods for treating or preventing vascular inflammation or for reducing blood levels of c-reactive protein by administering at least one sterol absorption inhibitor and/or at least one 5alpha-stanol absorption inhibitor.
Patent AU-2003254445-B2 (AU)
Title: Nucleic acid amplification method
Inventor: SKYNNER MICHAEL
IPC: C12Q1/6853
Filed: 2003-07-10
Granted: 2006-06-15
Abstract: A method for increasing the number of polynucleotides containing sequences corresponding to a mRNA species present in a sample, comprises the steps of: (i) reverse transcription of the RNA species using a heeled 5'-amplification primer (FAP-RAND) and a heeled 3'-amplification primer (TAP-RT), wherein each primer sequence is unique, and either or each heel sequence includes a RNA polymerase promoter site, and the FAP includes a variable sequence, whereby the RNA is reverse-transcribed to produce double-stranded cDNA and then multiple cDNAs according to the variable sequence; and (ii) amplification of the cDNA using primers sufficiently complementary to the primers, i.e., FAP and TAP, within FAP-RAND and TAP-RT. In one embodiment, the method additionally comprises the step of: (iii) in vitro transcription, to produce RNA run-offs from either end of the amplicons.
Patent AU-2003262486-B2 (AU)
Title: 802.1X Protocol-based multicasting control method
Inventor: LU RUIXIN
IPC: H04L12/18
Filed: 2003-11-25
Granted: 2008-10-09
Abstract: The present invention discloses an 802.1X protocol-based multicasting control method. According to the method, a device intercepts a request message for joining in a multicasting group, then obtains the port and MAC address information from the intercepted message, searches corresponding subscriber account information from the authenticated data according to said port and MAC address, then authenticates the subscriber's account number and multicasting IP address, and adds the subscriber to the multicasting group after successful authentication; therefore, controlled multicasting, authentication of the legality of adding to multicasting, and accounting can be achieved according to the method, which can also protect existing investment and compatibility with existing software of the subscriber. <IMAGE>
Patent AU-2003265770-B2 (AU)
Title: Power cycle with liquefied natural gas regasification
Inventor: MAK JOHN
IPC: F17C9/02
Filed: 2003-08-26
Granted: 2009-03-26
Abstract: Liquefied natural gas (LNG) or components thereof are used as working fluids in power generation cycles in a LNG regasification plant. Especially preferred plant configurations will be able to process LNG of different composition while generating on-spec pipeline gas, CNG, LNG vehicle fuel, and LPG.
Patent AU-2003301335-B2 (AU)
Title: Method of treating fibers, carpet yarns and carpets to enhance repellency
Inventor: JONES DENNIS J JR
IPC: D06M15/277
Filed: 2003-10-14
Granted: 2007-10-18
Abstract: Methods of enhancing repellency of fibers, carpet yarns and carpets are disclosed. Compositions used to enhance the repellency of fibers, carpet yarns and carpets are also disclosed.
Patent AU-2004223765-B2 (AU)
Title: Device for connecting building boards, especially floor panels
Inventor: LEWARK MATTHIAS
IPC: F16B5/00
Filed: 2004-01-30
Granted: 2009-12-03
Abstract: The device for the connecting and locking of especially floor panels (1,2) with a core made from a derived timber product has an insert (7) for fitting in respective slots in the side edges of the panels. The insert has at least one spring lip (7a) orientated towards the upper side (10) or lower side (11) of the panel, and may have two oppositely orientated lips. The spring lips each have a point (7c) extending at an angle to the upper of lower side and interacting with an angled edge for locking purposes.
Patent AU-2004237910-B2 (AU)
Title: Heat-shrinkable packaging films with improved sealing properties and articles made thereof
Inventor: POCKAT GREGORY ROBERT
IPC: B32B1/00
Filed: 2004-12-14
Granted: 2009-05-21
Abstract: A coextruded heat-shrinkable, biaxially-oriented multilayered packaging film comprising a first layer, a second polymer layer, a third polymer layer, and a fourth polymer layer wherein the first polymer layer comprises a first ethylene/±-olefin copolymer preferably, an ethylene/±-olefin copolymer having an ±-olefin comprising 4-8 pendant carbon atoms, a melting point of less than 105° C., a molecular weight distribution M  w  /M  n   of from 0.05- 2.7, a melt index of from 6.5-34 g/10 min. at 190° C., and is present in the first layer is an amount of from 50-100%, based on the total weight of said first layer. The second layer comprises a second ethylene/±-olefin copolymer having a melt index of from 0.85-6.0 g/10 min. Preferably, A is the cumulative total weight percentage of the first ethylene/±-olefin copolymer in all layers of the film and B is the cumulative total weight percentage of the second ethylene/±-olefin copolymer in all layers of the film, such that the relative amounts A and B satisfy the relationship 2A/B  1. The invention includes a package comprising the coextruded heat-shrinkable, biaxially-oriented multilayered packaging film.
Patent AU-2004240946-B2 (AU)
Title: Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
Inventor: ROWLEY ROBERT JOHN
IPC: C07D471/04
Filed: 2004-05-20
Granted: 2011-09-08
Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
Patent AU-2005235635-B2 (AU)
Title: Bone delivery conjugates and method of using same to target proteins to bone
Inventor: LOISEL THOMAS P
IPC: A61K47/64
Filed: 2005-04-21
Granted: 2010-11-18
Abstract: The invention relates to a pharmaceutical composition comprising a bone delivery conjugate having the structure Z-sALP-Y-Dn-X, wherein X is absent or is an amino acid sequence of at least one amino acid; Y is absent or is an amino acid sequence of at least one amino acid; Z is absent or is an amino acid sequence of at least one amino acid; Dn is a poly aspartate, wherein n=10 to 16; and sALP is a soluble alkaline phosphatase and uses thereof.
Patent AU-2005294535-B2 (AU)
Title: Multi-axial anchor assemblies for spinal implants and methods
Inventor: TAYLOR HAROLD S
IPC: A61B17/88
Filed: 2005-10-04
Granted: 2012-01-19
Abstract: Systems and methods are provided that include a plate member (120, 140, 160, 180, 600) engageable to the spinal column with an anchor assembly (20, 320, 420, 520, 620, 720). The anchor assembly (20, 320, 420, 520, 620, 720) includes a coupling member (30, 130, 330, 430, 530, 630) having a post (32, 332, 432, 532, 632, 732) extending through at least one opening of the plate member (120, 140, 160, 180, 600) and an anchor member (70) pivotally captured in a receiver portion (34, 334, 434, 534, 634) of the coupling member (30, 130, 330, 430, 530, 630) below a lower surface of the plate member (120, 140, 160, 180, 600). A locking member (90, 590) secures the plate member (120, 140, 160, 180, 600) to the coupling member (30, 130, 330, 430, 530, 630). A crown (50, 150, 250, 350, 550, 650) in the receiver portion (34, 334, 434, 534, 634) of the coupling member (30, 130, 330, 430, 530, 630) is engaged by the plate member (120, 140, 160, 180, 600) to secure the anchor member (70) in position relative to the coupling member (30, 130, 330, 430, 530, 630).
Patent AU-2005321780-B2 (AU)
Title: Coupling methods and architectures for information processing
Inventor: MAASSEN DEN BRINK ALEXANDER VAN
IPC: H01F37/00
Filed: 2005-12-30
Granted: 2011-08-18
Abstract: A structure comprising (i) a first information device, (ii) a second information device, (iii) a first coupling element and (iv) a second coupling element is provided. The first information device has at least a first lobe and a second lobe that are in electrical communication with each other. The second information device and has at least a first lobe and a second lobe that are in electrical communication with each other. The first coupling element inductively couples the first lobe of the first information device to the first lobe of the second information device. The second coupling element inductively couples the first lobe of the first information device to the second lobe of the second information device.
Patent AU-2005322648-B2 (AU)
Title: High discharge capacity lithium battery
Inventor: MARPLE JACK W
IPC: H01M50/463
Filed: 2005-04-01
Granted: 2011-08-11
Abstract: A lithium/iron disulfide electrochemical battery cell with a high discharge capacity. The cell has a lithium negative electrode, an iron disulfide positive electrode and a nonaqueous electrolyte. The iron disulfide of the positive electrode has a controlled average particle size range which allows the electrochemical cells to exhibit desired properties in both low and high rate applications. In various embodiments, the iron disulfide particles are wet milled, preferably utilizing a media mill or milled utilizing a non-mechanical mill such as a jet mill, which reduces the iron disulfide particles to a desired average particle size range for incorporation into the positive electrode.
Patent AU-2006283472-B2 (AU)
Title: Hybrid metal-plastic roof vent
Inventor: O'HAGIN HARRY T
IPC: E04D1/30
Filed: 2006-08-18
Granted: 2012-07-26
Abstract: A vent (10) for a tile roof (2) is disclosed. The vent (10) includes a first member (16) preferably substantially formed of a metal, a second member (14) preferably substantially formed of a plastic material, and a connector (12) attached to the underside of the second member (14). The second member (14) is positioned below and spaced apart from the first member (16). The first and second members (16), (14) together define a ventilation gap (15) therebetween. The first member (16) and second member (14) are preferably releasably connected to each other. The connector (12) is configured to connect with an air conduit (8). The connector (12) is further configured to be compatible with a plurality of sizes and types of air conduits (8). The ventilating gap (15) and the connector (12) are together configured to permit airflow between above the roof (2) and the air conduit (8).
Patent AU-2006314835-B2 (AU)
Title: Base platform for an artificial joint
Inventor: BAUM INES
IPC: A61F2/40
Filed: 2006-01-17
Granted: 2013-05-16
Abstract: The invention relates to a base platform (11) for an artificial joint, in particular for an artificial shoulder joint, wherein the platform can be anchored on the bone and serves as a support for an artificial joint component (15, 17) that can be provided both in the form of a shell component (15) for an anatomical configuration and also in the form of a ball component (17) for an inverse configuration, and wherein different joint components can be mounted on the platform.
Patent AU-2007209185-B2 (AU)
Title: Improved impeller and fan
Inventor: BROOM COLIN
IPC: F04D29/28
Filed: 2007-01-19
Granted: 2011-04-14
Abstract: An impeller for a fan, which impeller comprises a hub and one or more blades, wherein at least one blade has a radially inner portion which is aerofoil in section and a centrifugal accelerator portion which extends radially outwardly from the aerofoil portion. The aerofoil portion has a greater angle of attack than the accelerator portion.
Patent AU-2007211960-B2 (AU)
Title: Mediated plug-in registration of client applications and content providers with push content delivery system
Inventor: SHENFIELD MICHAEL
IPC: H04L29/02
Filed: 2007-08-28
Granted: 2009-08-13
Abstract: A method and apparatus for connecting a generic element to a content delivery architecture in a push content delivery system having the steps of: providing a mediator between the generic element and the content delivery architecture; extracting at the mediator metadata for the generic element; and registering the generic element with the content delivery architecture.
Patent AU-2007220434-B2 (AU)
Title: Beta-crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same
Inventor: SOUVIE JEAN-CLAUDE
IPC: A61K31/404
Filed: 2007-02-26
Granted: 2010-10-14
Abstract: Beta crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta (expressed in percentage in relation to the most intense line), an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Beta crystalline form of perindopril arginine salt of formula (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta (expressed in percentage in relation to the most intense line), an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Independent claims are included for: (1) a composition comprising (I) in combination with inert and nontoxic vehicles; and (2) the preparation of (I). ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor. No biological data given.
Patent AU-2007253453-B2 (AU)
Title: Corrosion inhibiting composition for non-ferrous metals
Inventor: KELLER ANJA
IPC: C10M161/00
Filed: 2007-05-15
Granted: 2012-01-19
Abstract: The invention relates an additive composition for use as a metal working fluid and a process for protection of metals, particularly zinc or aluminum, against corrosion or oxidative degradation. The composition comprises an additive mixture of an alkenyl succinic half ester, a substituted imidazoline compound and amine phosphate partial ester in a functional fluid.
Patent AU-2007265966-B2 (AU)
Title: Fused cyclic compounds
Inventor: YASUMA TSUNEO
IPC: A61K31/192
Filed: 2007-06-26
Granted: 2012-05-17
Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
Patent AU-2007278520-B2 (AU)
Title: Tab for a closure and process for making such tab
Inventor: EMMERZAAL AART LEENDERT
IPC: B65D17/34
Filed: 2007-07-16
Granted: 2013-09-12
Abstract: The invention relates to a tab (3) for a closure, comprising a tab body (5) having at one side a tab nose (10) for opening the closure, and at the other side a tab lever (11) having a finger opening (12) for activating the tab lever, which finger opening is surrounded by a distal lever part (13) connected by lateral lever legs (14) to the tab body, wherein in the lever legs are formed aligned hinge parts (16) in the form of lateral lever leg parts (17) of reduced bending strength, to a closure and container comprising such tab, and to a process for making such tab.
Patent AU-2007329531-B2 (AU)
Title: Vesicles of self-assembling block copolymers and methods for making and using the same
Inventor: HOLOWKA ERIC P
IPC: A61K47/48
Filed: 2007-11-30
Granted: 2013-10-10
Abstract: Vesicles of self-assembling block copolymers, e.g., diblock copolypeptides, as well as methods of making and using the same. Vesicles of the invention have a shell made up of block copolymers that include an intracellular transduction hydrophilic domain and a hydrophobic domain. In certain embodiments, the vesicles include an encapsulated active agent, e.g., a diagnostic or therapeutic agent. The vesicles find use in a variety of different application, including the intracellular delivery of active agents, e.g., diagnostic and therapeutic agents.
Patent AU-2007358254-B2 (AU)
Title: Transactional security over a network
Inventor: CARROTT RICHARD F
IPC: G06F21/00
Filed: 2007-09-04
Granted: 2013-09-12
Abstract: A system and method facilitates purchase transactions over a computer network, including the purchase of electronically storable items. The embodiments herein encrypt "customer information" in an encryption stream and cause the encryption stream to be transferred from the customer to a merchant in the purchase transaction. A verification entity receives the encryption stream which is sent by the merchant for identity verification and payment authorization. Then, the verification entity verifies the identifiers contained in the encryption stream and transfers an identity verification and payment authorization from the verification entity to the merchant. The encryption stream or unique transaction identifier can be added, by the merchant, to a purchased electronic item to create a personalized electronic item.
Patent AU-2008202468-B2 (AU)
Title: Compositions and Methods of Administering Tubulin Binding Agents for the Treatment of Ocular Diseases
Inventor: MARK WOOD
IPC: A61K9/06
Filed: 2008-06-04
Granted: 2011-08-11
Abstract: The present invention is directed to the administration of vascular targeting agents, particularly a tubulin binding agent, for the treatment of ocular neovascularization, ocular tumors, and conditions such as diabetic retinopathy, retinopathy of prematurity, retinoblastoma and macular degeneration.
Patent AU-2008216152-B2 (AU)
Title: A method of monitoring microbiological activity in process streams
Inventor: ENZIEN MICHAEL V
IPC: C12Q1/00
Filed: 2008-02-14
Granted: 2013-05-02
Abstract: An apparatus and method for monitoring microbiological activity in a process stream by measuring dissolved oxygen is disclosed. Bulk microbiological activity and surface associated biological activity are measured using this apparatus and method.
Patent AU-2008238215-B2 (AU)
Title: Ig-pConsensus gene vaccination protects from antibody-dependent immune pathology in autoimmune disease
Inventor: FERRERA FRANCESCA
IPC: C07K16/18
Filed: 2008-04-11
Granted: 2013-03-28
Abstract: The disclosure provides methods and compositions useful for treating autoimmune diseases and disorders. For example, the disclosure demonstrates that hypergammaglobulinemia and subsequent accelerated kidney disease can be suppressed by Ig minigene-induced CD8
Patent AU-2008256445-B2 (AU)
Title: Biomarker and method for determining an oxidative stress level
Inventor: RAMSAY STEVEN LEWIS
IPC: C12Q1/26
Filed: 2008-05-30
Granted: 2015-02-26
Abstract: The present invention relates to a biomarker and a method for determining an oxidative stress level in a biological sample, which employs co- factor-dependent oxidative stress parameters, as well as a kit adapted for carrying out such a method. Preferably the co-factor is tetrahydrobiopterin.
Patent AU-2008260266-B2 (AU)
Title: Housings for phased array monostatic sodar systems
Inventor: MANFREDI LOUIS
IPC: G06F40/00
Filed: 2008-05-22
Granted: 2014-01-23
Abstract: A housing (100) for a phased array monostatic sodar system with a transducer array (10) that emits and receives multiple generally conical main beams of sound along different primary axes. The housing (100) includes one or more upwardly-directed sidewalls (128, 129, 130) that define a volume between them that is open to the atmosphere at the top, to emit and receive the beams, and an upper lip (108) at the top of at least one sidewall (128, 129, 130), defining a curved perimeter at the top of at least some of the volume that closely conforms to the shape of at least one main beam at the location of the lip (108).
Patent AU-2008271269-B2 (AU)
Title: Wheel isolator coupling
Inventor: FAN XINJIAN
IPC: B62M21/00
Filed: 2008-05-27
Granted: 2012-02-16
Abstract: A wheel isolator coupling comprising a sprocket (10) for engaging a drive member, the sprocket fixedly connected to a first adaptor (20), the sprocket rotationally engaged with a shaft (60) through a first bearing (70), a wheel portion (40) fixedly connected to a second adaptor (30), the wheel portion rotationally engaged with the shaft through a second bearing (71), the first adaptor having at least one receiving portion, at least one compressible member (50) disposed within the receiving portion, the second adaptor (30) having a radially extending member for engaging the compressible member within the receiving portion, and the sprocket imparting no axial force to the first bearing (70).
Patent AU-2008278593-B2 (AU)
Title: Antimicrobial peptide, compositions , and methods of use
Inventor: STONE HONGRAN FAN
IPC: A61K38/00
Filed: 2008-07-28
Granted: 2015-04-09
Abstract: The present invention provides antimicrobial peptides that exhibit a broad range of antimicrobial activity to gram positive and gram negative bacteria, as well as fungi, mold, and virus. The antimicrobial peptide of the invention is a cationic peptide, and may contain an HIV-TAT or reverse HIV-TAT sequence, or derivative thereof. The present invention further provides antimicrobial compositions containing the cationic peptide. Such compositions are especially useful for topical application to the skin, hair, nail, vagina, urethra, ear, oral cavity, nasal passage, respiratory system, opthalmic region, and various mucosal regions. The compositions of the present invention improve the condition and/or appearance of the treated region, and are suited for long-term and/or routine use to, for example, prevent or prevent the recurrence of microbial infection. The present invention further provides kits for use in improving the condition or appearance of skin, nail, or treated area. These kits may facilitate ease of use, long-term storage, and/or efficacy of the compositions.